# MYXREDLIN

NDC: 0338-0126
Generic name: insulin human
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20190712

FDA application: BLA208157

## Active ingredients

- INSULIN HUMAN: 1 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0338-0126"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0338-0126
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=afca6e80-a802-49fb-a978-5fe28a173001